Similar articles

• Transient and slight thrombocytopaenia induced by etanercept during treatment of psoriatic arthritis.

  Stinco G, Piccirillo F, Patrone P. Stinco G, et al. Acta Derm Venereol. 2008;88(3):281-2. doi: 10.2340/00015555-0400. Acta Derm Venereol. 2008. PMID: 18480934 No abstract available.
• Intraarticular injection of anti-tumor necrosis factor: Comment on the letter by Arnold et al.

  Bliddal H. Bliddal H. Arthritis Rheum. 2004 Jun;50(6):2037-8. doi: 10.1002/art.20305. Arthritis Rheum. 2004. PMID: 15188385 No abstract available.
• [Therapy of psoriasis vulgaris and psoriatic arthritis with etanercept].

  Mrowietz U, Barth J, Boehncke WH, Rosenbach T, Wozel G. Mrowietz U, et al. J Dtsch Dermatol Ges. 2005 Jun;3(6):470-2. doi: 10.1111/j.1610-0387.2005.04541.x. J Dtsch Dermatol Ges. 2005. PMID: 15892851 German. No abstract available.
• Etanercept (Enbrel) -- an update.

  Goffe B. Goffe B. Skin Therapy Lett. 2004 Dec-2005 Jan;9(10):1-4, 9. Skin Therapy Lett. 2004. PMID: 15657632 Review.
• The treatment of psoriasis and psoriatic arthritis with etanercept: practical considerations on monotherapy, combination therapy, and safety.

  Yamauchi PS, Gindi V, Lowe NJ. Yamauchi PS, et al. Dermatol Clin. 2004 Oct;22(4):449-59, ix. doi: 10.1016/j.det.2003.12.002. Dermatol Clin. 2004. PMID: 15450340 Review.